Skip to main content
PMC home page
Journal of Clinical Laboratory Analysis logoLink to Journal of Clinical Laboratory Analysis
. 2005 Mar 8;19(2):36–39. doi: 10.1002/jcla.20053

Serum levels of neopterin and interleukin‐2 receptor in women with severe preeclampsia

Ilknur Kaleli 1, Babur Kaleli 2, Melek Demir 1,✉, Basak Yildirim 2, Nural Cevahir 1, Suleyman Demir 3
PMCID: PMC6807976  PMID: 15756710

Abstract

Preeclampsia continues to be a major cause of maternal and perinatal mortality and morbidity worldwide. The etiopathogenesis of preeclampsia is not fully understood. Neopterin and interleukin‐2 (IL‐2) production reflects cellular immunity. Our purpose was to determine the levels of neopterin and interleukin‐2 receptor (IL‐2R) in pregnant women with severe preeclampsia, and assess the implications of these findings in the pathophysiology of preeclampsia. Fourteen women with preeclampsia were compared with 14 healthy pregnant women. Serum levels of neopterin were measured by an enzyme‐linked immunoassay (ELISA), and IL‐2R levels were determined by an immunoassay method with an Immulite analyzer. The levels of neopterin and IL‐2R were significantly higher in the preeclamptic subjects than in normotensive women (P<0.05). There was a significant correlation between neopterin and IL‐2R. We found that serum neopterin and IL‐2R levels are increased in women with severe preeclampsia. The results of this study suggest that a T‐helper 1 (Th1) type immune mechanism is involved in the pathogenesis of preeclampsia. J. Clin. Lab. Anal. 19:36–39, 2005. © 2005 Wiley‐Liss, Inc.

Keywords: preeclampsia, pregnancy, neopterin, IL‐2R, immunity

REFERENCES

  • 1. Robillard PY. Interest in preeclampsia for researchers in reproduction. J Reprod Immunol 2002;53:279–287. [DOI] [PubMed] [Google Scholar]
  • 2. Dekker GA, Sibai BM. The immunology of preeclampsia. Seminars Perinat 1999;23:24–33. [DOI] [PubMed] [Google Scholar]
  • 3. American College of Obstetricians and Gynecologists . Hypertension in pregnancy Technical bulletin no. 219. Washington, DC; American College of Obstetricians and Gynecologists: 1996. [Google Scholar]
  • 4. Yoneyama Y, Sawa R, Suzuki S, et al. Relation between adenosine deaminase activities and cytokine‐producing T cells in women with preeclampsia. Clin Biochem 2002;35:303–306. [DOI] [PubMed] [Google Scholar]
  • 5. Mosmann TR, Sad S. The expanding universe of T‐cell subsets: Th1, Th and more. Immunol Today 1996;17:138–146. [DOI] [PubMed] [Google Scholar]
  • 6. Wegman TG, Lin H, Guilbert L, Mosmann TR. Bidirectional cytokine interactions in the maternal–fetal relationship: is successful pregnancy a Th2 phenomena? Immunol Today 1993;14:353–356. [DOI] [PubMed] [Google Scholar]
  • 7. Piccini MP, Maggi E, Romagnani S. Role of hormone‐controlled T‐cell cytokines in the maintenance of pregnancy. Biochem Soc Trans 2000;28:212–215. [DOI] [PubMed] [Google Scholar]
  • 8. Raghupathy R. Th1‐type immunity is incompatible with successful pregnancy. Immunol Today 1997;18:478–482. [DOI] [PubMed] [Google Scholar]
  • 9. Szekeres‐Bartho J, Wegmann TG. A progesterone‐dependent immunomodulatory protein alters the Th1/Th2 balance. J Reprod Immunol 1996;31:81–95. [DOI] [PubMed] [Google Scholar]
  • 10. Hill JA, Polger K, Anderson DJ. T helper I type immunity to trophoblasts in women with recurrent spontaneous abortion. JAMA 1995;2/3:1933–1936. [PubMed] [Google Scholar]
  • 11. Saito S, Sakai M, Sasaki M, Tanabe K, Tsuda H, Michihama T. Quantitative analysis of peripheral blood Th0, Th1, Th2 and the Th1:Th2 cell ratio during normal human pregnancy and preeclampsia. Clin Exp Immunol 1999;117:550–555. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Darmochwal‐Kolarz D, Leszczynska‐Gorzelak B, Rolinsli J, Oleszczuk J. T helper1‐ and T helper2‐type cytokine imbalance in pregnant women with preeclampsia. Eur J Obstet Gynecol Reprod Biol 1999;86:165–170. [DOI] [PubMed] [Google Scholar]
  • 13. Muller MM, Curtius HC, Herold M, Huber CH. Neopterin in clinical practice. Clin Chim Acta 1991;201:1–16. [DOI] [PubMed] [Google Scholar]
  • 14. Fuchs D, Weiss G, Wachter H. Neopterin, biochemistry and clinical use as a marker for cellular immune reactions. Int Arch Allerg Immunol 1993;101:1–6. [DOI] [PubMed] [Google Scholar]
  • 15. Huber C, Batchelor JR, Fuchs D, Hausen A, Lang A, Niederwieser D. Immune response‐associated production of neopterin. Release from macrophages primarily under control of interferon gamma. J Exp Med 1984;160:310–316. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 16. Fuith LC, Fuchs D, Hausen A, et al. Neopterin, a marker of cell‐mediated immune activation in human pregnancy. Int J Fertil 1991;36:372–375. [PubMed] [Google Scholar]
  • 17. Bichler A, Fuchs D, Hausen A, Hetzel H, Reibnegger G, Wachter H. Measurement of urinary neopterin in normal pregnant and nonpregnant women and in women with benign and malignant genital neoplasms. Arch Gynecol 1983;233:121–130. [DOI] [PubMed] [Google Scholar]
  • 18. Schröcksnadel H, Baier‐Bitterlich G, Dapunt O, Wachter H, Fuchs D. Decreased plasma tryptophan in pregnancy. Obstet Gynecol 1996;88:47–50. [DOI] [PubMed] [Google Scholar]
  • 19. MacLean MA, Wilson R, Thomson JA, Krishnamurthy S, Walker JJ. Immunological changes in normal pregnancy. Eur J Obstet Gynecol Reprod Biol 1992;43:167–172. [DOI] [PubMed] [Google Scholar]
  • 20. Fuchs D, Hausen A, Reibnegger G, Werner ER, Dierich MP, Wachter H. Neopterin as a marker for activated cell‐mediated immunity: application in HIV infection. Immunol Today 1988;9:150–155. [DOI] [PubMed] [Google Scholar]
  • 21. Munn DH, Zhou M, Attwood JT, et al. Prevention of allogenic fetal rejection by tryptophan catabolism. Science 1998;281:1191–1193. [DOI] [PubMed] [Google Scholar]
  • 22. Schröcksnadel H, Herold M, Steckel‐Berger G, Fuchs D, Wachter H, Dapunt O. Zellvermittelte immunitet bei schwangerschaftsinduzierten hochdruckerkrankungen. Geburtsh U Frauenheilk 1992;52:592–595. [DOI] [PubMed] [Google Scholar]
  • 23. Schröcksnadel H, Fuchs D, Herold M, Wachter H, Dapunt O. Aktivierte makrophagen im pathomechanismus schwangerschafts‐induzierter hochdruckerkrankungen. Zentralbl Gynacol 1994;116:274–275. [PubMed] [Google Scholar]
  • 24. Wachter H, Fuchs D, Hausen A, Reibnegger G, Werner ER. Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application. Adv Clin Chem 1989;27:81–141. [DOI] [PubMed] [Google Scholar]
  • 25. Darmochwal‐Kolarz D, Rolinski J, Leszczynska‐Gorzelak B, Oleszczuk J. The expressions of intracellular cytokines in the lymphocytes of preeclamptic patients. Am J Reprod Immunol 2002;48:381–386. [DOI] [PubMed] [Google Scholar]
  • 26. Madazlý R, Aydýn S, Uludag S, Vildan O, Tolun N. Maternal plasma levels of cytokines in normal and preeclamptic pregnancies and their relationship with diastolic blood pressure and fibronectin levels. Acta Obstet Gynecol Scand 2003;82:797–802. [DOI] [PubMed] [Google Scholar]
  • 27. Vince GS, Johnson PM. Immunobiology of human uteroplacental macrophages–friend and foe. Placenta 1996;17:191–199. [DOI] [PubMed] [Google Scholar]
  • 28. Hamai Y, Fujii T, Yamashita T, Kozuma S, Okai T, Taketani Y. Pathogenic implication of interleukin 2 expressed in preeclamptic decidual tissues: a possible mechanism of deranged vasculature of the placenta associated with preeclampsia. Am J Reprod Biol 1997;38:83–88. [DOI] [PubMed] [Google Scholar]
  • 29. Conrad KP, Benyo DF. Placental cytokines and the pathogenesis of preeclampsia. Am J Reprod Biol 1997;37:240–249. [DOI] [PubMed] [Google Scholar]
  • 30. Krauss T, Kuhn W, Lakoma C, Augustin HG. Circulating endothelial adhesion molecules as diagnostic markers for the early identification of pregnant women at risk for development of preeclampsia. Am J Obstet Gynecol 1997;177:443–449. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Laboratory Analysis are provided here courtesy of Wiley

RESOURCES